Arcutis Biotherapeutics, Inc. ARQT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $35.07M-34.7% | $43.22M-39.9% | $47.43M-65.0% | $73.05M-13.9% | $53.72M-71.8% | ||
| $189.24M+30.5% | $178.08M+13.7% | $143.95M-26.4% | $118.08M-57.5% | $144.98M-32.2% | ||
| $144.38M+69.0% | $146.23M+100% | $115.12M+91.5% | $106.69M+146% | $85.42M+130% | ||
| $37.39M+125% | $22.63M+55.8% | $22.42M+60.0% | $16.32M+17.6% | $16.61M+25.4% | ||
| $438.06M+35.3% | $411.23M+22.5% | $349.22M-17.6% | $332.78M-23.4% | $323.67M-30.8% | ||
| $1.04M-30.5% | $1.04M+0.2% | $1.22M+2.4% | $1.39M+3.5% | $1.5M+9.3% | ||
| $14.25M-13.6% | $14.81M+56.3% | $15.38M+57.0% | $15.94M+163% | $16.5M+164% | ||
| $460M+33.7% | $432.97M+24.1% | $370.98M-15.2% | $352.43M-20.8% | $344.11M-28.1% | ||
| $18.3M-25.4% | $12.53M-11.9% | $5.8M-70.0% | $15.08M+89.9% | $24.53M+89.1% | ||
| $7.95M— | $1M— | $1M-99.0% | $1M— | —— | ||
| $163.2M+79.1% | $129.84M+60.3% | $99.77M-42.1% | $103.94M+102% | $91.13M+92.6% | ||
| $101.47M-5.7% | $107.96M+0.7% | $107.5M+2.3% | $107.05M-47.5% | $107.62M-46.9% | ||
| $270.36M+34.2% | $243.49M+27.3% | $212.9M-24.2% | $213.46M-17.4% | $201.45M-20.6% | ||
| 300M0.0% | 300M+2,499,900% | 300M0.0% | 300M0.0% | 300M0.0% | ||
| -$1.15B-0.2% | -$1.14B-1.4% | -$1.16B-4.0% | -$1.16B-8.7% | -$1.15B-12.8% | ||
| $189.65M+32.9% | $189.48M+20.3% | $158.07M+0.9% | $138.97M-25.5% | $142.66M-36.6% | ||
| $460M+33.7% | $432.97M+24.1% | $370.98M-15.2% | $352.43M-20.8% | $344.11M-28.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Arcutis Biotherapeutics, Inc.'s total assets?
- Arcutis Biotherapeutics, Inc. (ARQT) holds $460.0M in total assets, up 33.7% year over year.
- How much debt does Arcutis Biotherapeutics, Inc. have?
- Arcutis Biotherapeutics, Inc. carries $114.7M in total debt against $189.6M of shareholders' equity, a debt-to-equity ratio of 0.60.
- How much cash does Arcutis Biotherapeutics, Inc. have?
- Arcutis Biotherapeutics, Inc. holds $35.1M in cash and equivalents.
- Can Arcutis Biotherapeutics, Inc. cover its short-term obligations?
- Its current ratio is 2.68 — current assets exceed current liabilities.
- Where does Arcutis Biotherapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Arcutis Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
